Absci Expands Scientific Advisory Board to Continue to Pioneer AI Drug Creation
Absci Corporation, a generative AI drug creation company, today announced the expansion of its Scientific Advisory Board with three world-class scientific leaders: Victor Greiff, Ph.D., Timothy Lu, MD, Ph.D., and Hubert Truebel, MD, Ph.D., MBA.
Source: azorobotics.com